1-4 of 4
Miroslav Koulnis
Close
Sort by
Journal Articles

The Biologic Relevance of PIM Kinases in the Context of Multiple Myeloma and Their Potential As Therapeutic Targets in Combination Drug Therapy

Janani Ramachandran, MA, Loredana Santo, MD, Homare Eda, MDPhD, Dharminder Chauhan, PhD, Ka Tat Siu, PhD, Miroslav Koulnis, PhD, Dennis Huszar, PhD, Kenneth C Anderson, MD, Noopur S. Raje, MD
Journal: Blood
Blood (2015) 126 (23): 2992.
https://doi.org/10.1182/blood.V126.23.2992.2992
Published: 2015
Journal Articles

Effect of the BET Inhibitor, Cpi-0610, Alone and in Combination with Lenalidomide in Multiple Myeloma

Ka Tat Siu, PhD, Homare Eda, MDPhD, Loredana Santo, MD, Janani Ramachandran, MA, Miroslav Koulnis, PhD, Jennifer Mertz, PhD, Robert J. Sims, PhD, Michael Cooper, MD, Noopur S. Raje, MD
Journal: Blood
Blood (2015) 126 (23): 4255.
https://doi.org/10.1182/blood.V126.23.4255.4255
Published: 2015
Journal Articles

Novel In Vivo Model of Multiple Myeloma Bone Disease Using ß-Tricalcium Phosphate Artificial Bone Grafts

Miroslav Koulnis, PhD, Homare Eda, MDPhD, Loredana Santo, MD, Ka Tat Siu, PhD, Janani Ramachandran, MA, Cristina Panaroni, PhD, Takaaki Tanaka, MD PhD, Noopur S. Raje, MD
Journal: Blood
Blood (2015) 126 (23): 4200.
https://doi.org/10.1182/blood.V126.23.4200.4200
Published: 2015
Journal Articles

Contrasting dynamic responses in vivo of the Bcl-x L and Bim erythropoietic survival pathways

Miroslav Koulnis, Ermelinda Porpiglia, P. Alberto Porpiglia, Ying Liu, Kelly Hallstrom, Daniel Hidalgo, Merav Socolovsky
Journal: Blood
Blood (2012) 119 (5): 1228–1239.
https://doi.org/10.1182/blood-2011-07-365346
Published: 2012
Includes: Supplemental data